CyberLink Collaborates with AMD to Bring On-Device Generative AI to a Broader Audience
Compared to a traditional PC, next-Gen AI PCs utilizing the latest AMD Ryzen™ AI processors allow for CyberLink's award winning video editor, PowerDirector, to run on the NPU for high-load tasks, such as when rendering PowerDirector's AI Body Effects. In doing so, the GPU and CPU are freed up to handle other editing tasks, like rendering additional effects, color correction, and audio enhancements.
Combining CyberLink's leading multimedia audio and video processing and AI technology with AMD's innovative technology in the field of high-performance processors shows the powerful strength of software and hardware integration, while promoting the innovative application of generative AI and digital content editing technology.
"CyberLink is excited to work with AMD to further the potential of AI PCs. We look forward to continuing to develop new, NPU optimized, on-device, Gen-AI tools for improved productivity and privacy protection, including those for Promeo, CyberLink's creative studio for online selling and marketing. When available on-device via AMD Ryzen™, Promeo's AI Magic Designer and AI Cowriter will enable users to quickly generate marketing content inclusive of images, text, and templates based on simple text prompts," said Vincent Lin, Co-President of CyberLink.
About CyberLink
Founded in 1996, CyberLink Corp. (5203.TW) is a leading provider of digital creative editing software and artificial intelligence (AI) solutions, inclusive of facial recognition. A driver of innovation, CyberLink has embraced the transformative power of AI, harnessing it to address the demands of consumer, commercial and education markets through a wide range of solutions. From the award-winning Director Suite's PowerDirector, PhotoDirector and Promeo, to the acclaimed AI facial recognition engine, FaceMe®, CyberLink is committed to providing exceptional experiences. Empowering creators and marketers of all skill levels, Director Suite elevates the content creation process, while FaceMe® delivers the fast and accurate facial recognition that is key to AIoT applications for security and surveillance.
To learn more about Director Suite, visit the CyberLink website: https://www.cyberlink.com/
For more information about CyberLink's AI facial recognition engine, visit the FaceMe® website: https://www.cyberlink.com/faceme
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513239882/en/
Contacts
Press Contactspress@cyberlink.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
mAbxience Announces European Commission Approval of Denosumab Biosimilars
MADRID, July 2, 2025 /PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, is pleased to announce that the European Commission has granted approval for its denosumab biosimilars Denbrayce® and Izamby®. This approval follows a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) and represents a major milestone in mAbxience's mission to provide high-quality, accessible, and affordable therapies worldwide. Denbrayce®, referencing Amgen's Xgeva®, is indicated for the prevention of skeletal-related events in adults with advanced malignancies involving bone, as well as for the treatment of adults and skeletally mature adolescents with giant cell tumor of bone. Izamby®, referencing Amgen's Prolia®, is indicated for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures, a condition that causes bones to become weak and more prone to breaking. "This approval is a testament to mAbxience's dedication to scientific excellence and our commitment to broadening access to essential biologic therapies," said Jurgen Van Broeck, CEO of mAbxience. "We are proud to contribute to reducing the burden of osteoporosis, cancer-related bone conditions, and rare bone diseases in Europe. This milestone brings us one step closer to ensuring that more patients across Europe can benefit from high-quality, affordable treatment options." Denosumab is a human monoclonal antibody that works by inhibiting the receptor activator of nuclear factor kappa-B ligand (RANKL), thereby preventing the development of osteoclasts, the cells responsible for bone breakdown. It is a well-established treatment for osteoporosis, treatment-induced bone loss, bone metastases, and giant cell tumor of bone. With the approval of these biosimilars mAbxience further demonstrates its expertise in the development and production of biosimilars, reinforcing its contribution to improving patient access to life-changing therapies and supporting the sustainability of healthcare systems across Europe. This approval marks another important step in mAbxience's mission to provide affordable, accessible and life-changing therapies worldwide. With a robust pipeline and a growing network of partners, mAbxience continues to enhance patient access to advanced treatments while supporting healthcare systems in managing the rising costs of biologic medicines. About mAbxience mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. In August 2022, Fresenius Kabi and Insud Pharma entered into an agreement whereby Fresenius Kabi, an operating company of Fresenius, acquired a majority stake of mAbxience, making it a global, vertically integrated biotechnology company. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South America, have obtained GMP approval from esteemed regulatory bodies, including the FDA, EMA, and others. Furthermore, as a global biopharmaceutical expert, mAbxience specializes in Contract Development and Manufacturing Organization services (CDMO), utilizing advanced technology and innovative platforms to deliver integrated manufacturing solutions. For more insights into mAbxience, our biosimilars and CDMO business, please visit our website ( or connect with us on LinkedIn. Photo: View original content to download multimedia: SOURCE mAbxience Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
14 minutes ago
- Associated Press
NA-LUBE AW-6110 Officially Included on the LuSC-List
At King Industries, we know the path to EU Ecolabel certification starts with high-performance, eco-compatible chemistries. Our portfolio of lubricant additives and base oil modifiers contains many products that have been assessed and included on the Lubricant Substance Classification list (LuSC-list). NORWALK, CT / ACCESS Newswire / July 2, 2025 / Whether you're developing hydraulic fluids, greases, or gear oils, King Industries, Inc. products help meet the demanding criteria of the EU Ecolabel while providing exceptional performance. Now officially included on the LuSC-list, NA-LUBE® AW-6110, the multifunctional, ashless antiwear additive is King's newest tool for use in environmentally responsible lubricants. Why choose NA-LUBE® AW-6110? NA-LUBE® AW-6110 has excellent solubility in a variety of base fluids, allowing for versatile use in many applications, including: Ready to formulate for the future? Whether you are looking to update existing products or develop new formulations that meet EU Ecolabel requirements, our team is here to help. Contact our technical team today to request a sample or formulation guidance. Let's build greener, more efficient lubricants - together. Have questions or just curious? Reach out to us-no pressure, no commitment. Contact us below! Contact Information Willi Gartner Sales Manager - Lubricant Additives 203-866-5551 SOURCE: King Industries, Inc. press release
Associated Press
15 minutes ago
- Associated Press
IDEMIA Public Security Joins TSA Launch of $25 TSA PreCheck® Discount for Military Spouses
TSA's military benefits for new TSA PreCheck® enrollments and renewals will be available at 500+ enrollment centers nationwide. RESTON, Va., July 2, 2025 /PRNewswire/ -- IDEMIA Public Security North America, the leading provider of secure and trusted biometric-based solutions, and an authorized enrollment provider for TSA PreCheck® since 2013, announced today as part of TSA's 'Serve with Honor, Travel with Ease' campaign: a $25 discount on TSA PreCheck enrollment and renewals for military spouses and free TSA PreCheck enrollments to Gold Star families. While U.S. military members are eligible for TSA PreCheck at no cost as a benefit of their employment, this new TSA offer extends that convenience to their spouses — as travel volumes this summer reach record highs. TSA PreCheck enrollment provided by IDEMIA costs $76.75 and covers five years of membership, offering significant value and long-term travel benefits. Through this special discount, military spouses can enroll for just $51.75, and Gold Star Families can enroll for free. Enrolled travelers enjoy dedicated TSA PreCheck security lanes at the airport and the convenience of keeping shoes, belts, light jackets on, and 3-1-1 liquids, and laptops in their bags. In addition, children 17 and under may accompany enrolled adults at the TSA PreCheck lanes when traveling on the same reservation, and the TSA PreCheck indicator appears on their boarding pass. 'This Independence Day and beyond, TSA reaffirms its commitment to ease travel for the military community through its TSA PreCheck program, by providing it free to Gold Star families, discounting it for active-duty spouses and creating expedited lanes for service members in uniform,' said TSA Acting Administrator Ha Nguyen McNeill. 'By expanding access, easing enrollment, and partnering with our TSA PreCheck enrollment providers and industry partners, we strive to honor those who serve and the families who stand beside them.' As part of its broader commitment to military personnel and veterans, IDEMIA supports employees through VERG, its Veteran Employee Resource Group, which is centered around a mission to embrace IDEMIA's proud community of employee veterans and provide support through shared experiences, veteran recruitment, career development, access to resources and information, and outward engagement. Additionally, IDEMIA participates in the Department of Defense (DOD) Skillbridge Program, offering active-duty U.S. military members valuable hand-on experience as they transition into civilian careers during their final months of their service. 'As someone who proudly served in the U.S. Army, I'm honored to see IDEMIA's continued support of the military community through this offering,' shared Patrick Clancey, CEO, IDEMIA National Security Solutions and Executive Advisor to IDEMIA's Veteran Employee Resource Group. 'This initiative recognizes the sacrifices military families make every day and gives them one less thing to worry about, especially when every moment with loved ones counts. To ease the travel experience of those who give so much is truly meaningful, and we're glad to be part of it.' As a longstanding partner helping drive TSA's enrollment mission forward, IDEMIA has processed more than 24 million enrollments for the TSA PreCheck program to date. With the goal of making TSA PreCheck enrollment accessible and convenient, IDEMIA runs an extensive nationwide network of over 500 enrollment centers nationwide which are located at IdentGo locations, select airports, and local businesses, providing travelers options on where to enroll. IDEMIA also offers pop-up TSA PreCheck enrollment events throughout the country, collaborating with organizations such as AAA. IDEMIA provides ample appointment availability, with most locations offering next-day availability, and all locations having availability within the next two weeks. To learn more about IDEMIA 's enrollment services for TSA PreCheck and other TSA enrollment programs, click enjoy the benefits of TSA PreCheck, travelers can enroll at any of IDEMIA's enrollment centers or at a local pop-up event. To get started visit: For more information on TSA PreCheck offers for uniformed service members, visit About IDEMIA Group IDEMIA Group unlocks simpler and safer ways to pay, connect, access, identify, travel, and protect public places. With its long-standing expertise in biometrics and cryptography, IDEMIA develops technologies of excellence with an impactful, ethical, and socially responsible approach. Every day, IDEMIA secures billions of interactions in the physical and digital worlds. IDEMIA Group brings together three market-leading businesses that enable mission-critical solutions: With a global team of nearly 15,000 employees, IDEMIA Group is trusted by over 600 governmental organizations and more than 2,400 enterprises in over 180 countries. For more information, visit and follow @IDEMIAGroup on X. Media contact: Genevieve de Vera IDEMIA Public Security (978) 808-7047 [email protected] View original content to download multimedia: SOURCE IDEMIA Identity & Security USA LLC
